Ergoteles’s Arvinas ARVN Stock Holding History

Ergoteles’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,438	Closed	-$568K	–	1625
2022 Q1	$568K	Buy	+8,438	New	+$575K	0.02%	624
2021 Q4	–	Sell	-6,200	Closed	-$510K	–	1224
2021 Q3	$510K	Buy	+6,200	New	+$548K	0.02%	571

Other funds holding ARVN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Ergoteles's ARVN Position: Q2 2022 in Review

Ergoteles sold out of Arvinas (ARVN) in Q2 2022, closing a stake of 8,438 shares — an estimated $568K sold.

Ergoteles first reported a position in ARVN in Q3 2021 and held it in 2 quarters. The position peaked at $568K in Q1 2022. 171 funds tracked by Wall St. Rank hold ARVN as of Q2 2022.

Ergoteles reported no remaining Arvinas position as of Q2 2022 after selling out during the quarter.
Ergoteles sold 8,438 Arvinas shares in Q2 2022, an estimated $568K.
Ergoteles first reported a position in Arvinas in Q3 2021 and held it in 2 quarters.
Ergoteles's Arvinas position peaked at $568K in Q1 2022.
171 funds tracked by Wall St. Rank held Arvinas as of Q2 2022.

Based on Ergoteles's 13F filing for Q2 2022, filed 12 Aug 2022.